Anti-EGFRvIII [L8A4] | Absoluteantibody貨號Ab00184-1.1

| 代理廠牌: | ![]() |
| 原廠連結: | |
| 相關下載: |
Fc Silent™ Antibodies: Turning down the background noise 只要訊號不要雜訊 (Engineered Fc Domain)
Anti-EGFRvIII [L8A4]
Absoluted Antibody 提供一系列抗體商品,其中Fc Silent™ Antibodies系列;能有效降低非特異性Fc結合。Fc Silent™技術,為應用生物工程技術,將Fc receptors (FcγR, FcR)點突變,進而中止抗體與ADCC的功能;有效降低Fc所造成的背景訊號。Fc Silent™抗體應用於免疫細胞時flow cytometry、immunohistochemistry (IHC)資料顯示,有效降低非特異性之Fc結合,所造成的背景值。(訂購抗體前,請確認選擇抗體是否有Fc Silent™修飾標誌)。
產品介紹 Anti-EGFRvIII [L8A4] | 貨號Ab00184-1.1
Description: Recombinant monoclonal antibody to EGFRvIII. Manufactured using AbAb’s Recombinant Platform with variable regions (i.e. specificity) from the hybridoma L8A4.
Species and Isotype: Mouse IgG1, kappa
Clone Number: L8A4
UniProt Accession Number of Target Protein: P00533
Alternative Name(s) of Target: Epidermal Growth Factor Receptor variant III
Published Application(s): IF; IHC; Biacore; WB; ELISA; FC
Published Species Reactivity: Human
Immunogen: Pep 3-KLH (Pep 3 is a 14-amino acid peptide corresponding to the predicted amino acid sequence at the fusion junction and KLH stands for keyhole limpet hemocyanin) at da 40 and 103, HC2 20 d2 cells at day 1, 25, 74, 87. And fusion with the nonimmunoglobulin-secreting Kearney variant of P3X63/Ag8.653.
Specificity: Binds EGFRvIII, a mutated form of EGFR, plays a prominent role in tumorigenesis.
Application Notes: This antibody can be used to detect EGFRvIII, a mutated EGFR variant, in immunohistochemical staining, Western Blot, ELISA and flow-cytometry. Chou et al (2016, PMID: 27825958) used this antibody to detect EGFRvIII in acetone and PFA fixed sections by fluorescent immunohistochemistry.
Antibody First Published in:
Wikstrand CJ, Hale LP, Batra SK, Hill ML, Humphrey PA, Kurpad SN, McLendon RE, Moscatello D, Pegram CN, Reist CJ, et al. Monoclonal antibodies against EGFRvIII are tumor specific and react with breast and lung carcinomas and malignant gliomas. Cancer Res. 1995 Jul 15;55(14):3140-8. PMID:7606735 Note on publication: Describes the preparation anti human EGFRvIII antibody by long-termimmunization protocols using the EGFRvIII-specific synthetic peptide and the intact variant. Identified using ELISA, Western blot, flow cytometry, and immunohistochemistry techniques.
Purification: Protein A affinity purified
Storage Recommendation: Store at 4°C for up to 3 months. For longer term storage aliquot into small volumes and store at -20°C
Concentration: See vial label.
